Toggle light / dark theme

Little-used cholesterol test could prevent more heart attacks and strokes

A routine blood test taken by millions in the U.S. each year to measure “bad” cholesterol is not the best measure to guide treatment and prevent heart attacks and strokes, suggests a new Northwestern Medicine study published in JAMA. The study found that another blood test called apolipoprotein B (apoB) outperformed LDL and non-HDL cholesterol in guiding cholesterol-lowering therapy, such as taking statins and other medications.

“We found that apoB testing to intensify cholesterol-lowering medication would prevent more heart attacks and strokes than current practice, and that these health benefits were achieved at a cost that represents good value for U.S. health care payers,” said study lead author Ciaran Kohli-Lynch, assistant professor of preventive medicine in the division of epidemiology at Northwestern University Feinberg School of Medicine.

According to Kohli-Lynch, this is the first comprehensive study to show that using apoB testing to guide cholesterol-lowering treatment is cost-effective.

A ‘stemness checkpoint’ helps control stem cell identity

A study published in Cell Research advances a central idea in stem cell biology by identifying a checkpoint that controls the identity of many different types of stem cells across developmental stages. For nearly two decades, scientists have understood that stem cell self-renewal depends on blocking differentiation signals—a concept described in earlier work, including Qi-Long Ying and Austin Smith’s 2008 Nature paper titled “The ground state of embryonic stem cell self-renewal.”

Now, researchers from the labs of Ying at USC and Guang Hu at the National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health (NIH), have identified the protein GSK3α as a “stemness checkpoint” that drives differentiation and that can be inhibited to maintain stem cell identity.

This discovery introduces a new conceptual framework: Rather than viewing stem cell maintenance as the result of many unrelated signaling conditions, distinct stem cell types share common checkpoints.

Microsoft rolls out fix for broken Windows Start Menu search

Microsoft has pushed a server-side fix for a known issue that broke the Windows Start Menu search feature on some Windows 11 23H2 devices.

In a Windows release health update (WI1273488) seen by BleepingComputer, Microsoft said these problems have affected only a small number of users since April 6 and are caused by a server-side Bing update aimed at improving search performance.

While the company says these problems are recent, there have been reports of similar issues surfacing online for months, including claims that the Start Menu displays blank search results that are still clickable.

Abstract: Detailing the effects of a new therapeutic tuberculosis vaccine!

https://doi.org/10.1172/JCI196648 In this Research Article, Styliani Karanika & team report on an intranasal DNA vaccine that accelerates TB cure and achieves better outcomes than standard or drug-resistant regimens alone in preclinical models.

The figure shows mouse lungs with therapeutic intranasal Mip3a/relMt b fusion immunization, revealing local dendritic cell infiltration and enhanced colocalization with T cells.


1Center for Tuberculosis Research, Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

2W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

3Division of Hematological Malignancies, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Hospital, Baltimore, Maryland, USA.

New genetic risk score better predicts diabetes, obesity and downstream complications

Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features. A polygenic risk score (PRS) can capture multiple genetic risk factors to provide an estimate for whether a person may develop a complex medical condition and how they might fare long-term.

Building stronger genetic risk scores By integrating genetic findings from several of the world’s largest biobanks, investigators from Mass General Brigham built metabolic PRSs for predicting obesity and T2D, which outperformed existing disease-prediction models and predicted downstream morbidity and clinical interventions. Findings are published in Cell Metabolism.

“Our intention was to not only capture the risk of being diagnosed with obesity or diabetes, but also to better predict health consequences across the life course by integrating many aspects of metabolic function,” said co-first author Min Seo Kim, MD, MSc.

Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial

In this multicenter randomized clinical trial, 24 months of moderate to vigorous aerobic exercise, intensive pharmacological reduction of blood pressure and serum LDL cholesterol, or the combination of these interventions did not significantly improve global cognitive function compared to usual care in older adults with hypertension and either family history of dementia or subjective cognitive decline.

Exercise and intensive vascular risk reduction each improved cardiovascular parameters, but no group differences were observed for changes in the Preclinical Alzheimer Cognitive Composite or NIH Toolbox Cognition Battery scores.


Question Can exercise, intensive pharmacological reduction of blood pressure (BP) and serum low-density lipoprotein cholesterol (LDL-C), or the combination of these interventions improve cognitive function in older adults with family history of dementia and/or self-reported subjective cognitive decline?

Findings In this randomized clinical trial of 513 participants, moderate to vigorous aerobic exercise training, intensive pharmacological lowering of BP and serum LDL-C, or both did not result in statistically significant differences in improvements in global cognitive function over 24 months.

Meaning The findings do not provide evidence in support of exercise, intensive reduction of BP and serum LDL-C, or both for improving cognitive function in older adults with family history of dementia and/or self-reported subjective cognitive decline.

How beliefs about demons shape the experience of mental illness

For some evangelical Christians, attributing mental illness to demonic forces can offer a sense of meaning, while for others, it creates harmful barriers to medical care. A recent qualitative study published in Spirituality in Clinical Practice outlines how these widespread spiritual explanations act as a double-edged sword for individuals experiencing psychological distress. The research indicates that integrating religious beliefs with standard psychiatric care may be a safer path forward for many faith communities.

Religion frequently shapes how people interpret their physical and mental health. Psychologists recognize that religious frameworks offer a primary system for individuals to make sense of the world around them. By relying on theological teachings, people construct meaning around their personal suffering. This process of religious meaning construction can influence health outcomes in both positive and negative directions.

Within evangelical Christianity, foundational teachings often emphasize the active existence of spiritual forces. This includes the belief that angels, demons, and other supernatural entities directly influence the physical world. This worldview can lead to the belief that spiritual forces cause human ailments, including severe psychological distress.

Transcranial magnetic stimulation can target a deep brain region without surgery or medication

Neuroscientists at University of Iowa Health Care have demonstrated for the first time that noninvasive brain stimulation can alter the activity of a critical deep brain region involved in emotion and memory. Moreover, the study shows that personalizing the stimulation site using a patient’s unique brain connectivity pathway can increase the neuromodulation effect.

The study, published recently in Nature Communications, used innovative, concurrent brain stimulation and recording techniques in people to provide direct human evidence that noninvasive transcranial magnetic stimulation (TMS) can reliably engage and modulate activity in the hippocampus.

The hippocampus is a deep brain region that plays a critical role in multiple brain functions, such as memory and emotion. Problems with hippocampal function have been implicated in several neurological and neuropsychiatric conditions, including Alzheimer’s disease, depression, anxiety, and post-traumatic stress disorder (PTSD).

New sensor could allow MRIs to see molecular-level changes

You’ve seen people sliding into the tube of a magnetic resonance imaging (MRI) machine on your favorite medical drama, or maybe you’ve been inside one yourself, waiting as the noisy scanner makes images of your brain, heart, bones, or other structures, which doctors use to identify injury or disease.

Since the 1970s, MRIs have been important diagnostic tools, combining a magnetic field and radio waves to produce snapshots of the body’s interior without using ionizing radiation, which can create health risks at higher doses. An MRI can typically capture changes in anatomy, but the molecular-level changes that could further aid understanding of disease have been beyond its reach.

Now, in a new article in Science Advances, University of California, Santa Barbara researchers report the invention of a modular, genetically encoded, protein-based sensor that enables MRI machines to visualize molecular activity inside cells—a development that could transform how scientists study cancer, neurodegeneration, and inflammation.

/* */